HIV Media Digest 15 Mar

Paul Kidd — Sun, 14 Mar 2010 14:23:36 -0700

Chinal mulls immig. law change after Dessaix incident … gay marriages in Mexico

Submission to Inquiry into the Migration Treatment of Disability

Graham Stocks — Thu, 11 Mar 2010 19:06:51 -0800

The Minister for Immigration and Citizenship, and the Parliamentary Secretary for Disabilities and Children's Services, have asked the Joint Standing Committee on Migration to undertake an inquiry relating to the health requirement in the Migration Act.

NAPWA has made a Submission to this enquiry.

Clinical Trial Action Group Public Submissions

Scott Lockhart — Thu, 11 Mar 2010 14:44:26 -0800

NAPWA recently contributed to the ClinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. TrialA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. Action Group. NAPWA has been closely engaged in clinical trials involving PLHIVPerson (or people) Living with HIV. This term is now preferred over the older PLWHA. throughout its history.

People Living With HIV/AIDS - South Australia seek Executive Officer

Graham Stocks — Thu, 11 Mar 2010 14:13:28 -0800

PLWHAPerson (or People) Living with HIV/AIDS. -SA are advertising for an Executive Officer.

They are seeking an innovative leader who intuitively engages with community and high-level stakeholders to effect social justice and change.

Applications close 10am Monday March 29th 2010.

For further information or to download the Position Description go to www.hivsa.org.au

HIV Media Digest 12 Mar

Paul Kidd — Thu, 11 Mar 2010 13:38:16 -0800

Dessaix visa outrage … Singapore … e-health … Abbott's ant-gay remarks

HIV Media Digest 5 Mar

Paul Kidd — Thu, 04 Mar 2010 14:18:48 -0800

HIV/AIDS leading cause of death in women … US calls to lift gay blood ban …

DO YOU LIKE US?

Graham Stocks — Wed, 03 Mar 2010 21:54:24 -0800

Thank you to everyone who completed our recent readership survey. Most of the feedback was extremely positive and your comments highly constructive.

One thing we’ve learned is that a lot of you have been reading Positive Living for a number of years (50% of you for more than five years). This tells us we have a very loyal readership, which is heartening.

Generic drug breakthrough

Graham Stocks — Wed, 03 Mar 2010 21:48:31 -0800

UNITAID, the international finance mechanism for drugs to treat HIV, tuberculosis and malaria, has given the go-ahead for a patent pool for antiretroviralA medication or other substance which is active against retroviruses such as HIV. drugs, a mechanism to promote wider licensing of patented drugs to generic manufacturers, in order to lower the cost of treatment.

Three treatments for the price of one

Graham Stocks — Wed, 03 Mar 2010 21:40:39 -0800

For the cost of a single PBS[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. script, Australians now have access to Atripla, the first HIV medication to combine three treatments in a single once-a-day tablet.

The new pill contains 300mg tenofovir + 200mg emtricitabine + 600mg efavirenz and is available for those either starting treatment for the first time or changing from other HIV treatments.

Fosamprenavir linked to heart problems

Graham Stocks — Wed, 03 Mar 2010 21:34:59 -0800

In December, GlaxoSmithKline (GSK) issued a letter alerting clinicians to the potential association between use of their protease inhibitor fosamprenavir (Telzir) and dyslipidemia (abnormal blood fatA fat. levels) and myocardial infarction (heart attackA life-threatening emergency in which the blood supply to the heart is suddenly cut off, causing the heart muscle (myocardium) to die from lack of oxygen.).

HIV legal website launched

Graham Stocks — Wed, 03 Mar 2010 21:23:05 -0800

AIDSLEX is an international tool for activists, community organisations, researchers, policymakers, journalists, health workers and anyone who wants quick and easy access to a wide range of resources about HIV, human rights and the law.

The central component of the website is a database of over 2700 documents (and growing) on a range of human rights and legal issues related to HIV.

Microbicide and vaccine both hit snags

Graham Stocks — Wed, 03 Mar 2010 21:15:30 -0800

PRO 2000, the microbicide gel, has failed to protect women against HIV infection in the largest microbicide studyA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. to date.

What's your problem?

Graham Stocks — Wed, 03 Mar 2010 19:56:43 -0800

Doctor Louise answers readers' questions. In this issue she discusses the value of seeing an HIV GP.

RESISTING RESISTANCE

Graham Stocks — Wed, 03 Mar 2010 17:53:07 -0800

Developing resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. to HIV is by no means a certainty but it is certainly something you want to avoid. Neil McKellar-Stewart explains what it is, how it comes about and what you can do about it.

Are we running out of GPs?

Graham Stocks — Wed, 03 Mar 2010 17:41:56 -0800

Why would anyone choose to specialise in HIV medicine? And what possible incentives are there to make you stay? These are questions you may well have contemplated while sitting in your own doctor’s waiting room.

International figures both good and bad

Graham Stocks — Wed, 03 Mar 2010 16:33:16 -0800

Increasing access to antiretroviralA medication or other substance which is active against retroviruses such as HIV. therapy is finally starting to have a positive impact on the global epidemic.

Dental scheme continues

Graham Stocks — Wed, 03 Mar 2010 16:23:21 -0800

It looked like it wouldn’t last, but the Medicare Enhanced Primary Care (EPC) Dental Scheme appears likely to continue into the foreseeable future.

Under the scheme, you are able to claim up to $4,250 in Medicare Benefits over two consecutive calendar years. The two-calendar year period is counted from the calendar year of your first dental service.

CROI 2010: All that's new in HIV

Graham Stocks — Wed, 03 Mar 2010 14:50:23 -0800

The Conference on Retroviruses and Opportunistic Infections (CROI) has just happened in San Francisco. This meeting is held annually and focuses on the very latest in basic science and clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. research. Jo Watson was there and gives us an overview.

HIV Media Digest 3 Mar

Paul Kidd — Tue, 02 Mar 2010 14:14:02 -0800

Rapid testing … stem cell therapy … pharma lobbyists … hospitals

HIV Media Digest 1 Mar

Paul Kidd — Sun, 28 Feb 2010 11:11:47 -0800

UK women ignoring HIV risk … CROI … Test-and-treat

Tales from The Network

Graham Stocks — Thu, 25 Feb 2010 21:39:43 -0800

There is a network of workers located at AIDS Councils and PLHIVPerson (or people) Living with HIV. This term is now preferred over the older PLWHA. organisations around Australasia who understand the variety of treatment issues faced by positive people. We call them the Treataware Outreach Network.

ADRIAN OGIER thought it was time we shared some of their stories.

Double Whammy

Graham Stocks — Thu, 25 Feb 2010 21:02:57 -0800

The complications associated with HIV and syphilis can be extreme. Unfortunately, Alan Bartlett found this out the hard way.

Are you clean?

Graham Stocks — Thu, 25 Feb 2010 20:11:08 -0800

It has become a favourite on online dating sites as the ‘polite’ way to ask about HIV status. Just for the record, it is not polite. It is both stigmatising and discriminatory.

Twenty five years on, do we still suffer stigma and discrimination? David Menadue finds that, in some areas particularly, we still do.

HIV Media Digest 24 Feb

Paul Kidd — Tue, 23 Feb 2010 11:30:49 -0800

Art class ousted … Global Fund … ‘Test and treat’ … Abbott welfare crackdown

HIV Media Digest 22 Feb

Paul Kidd — Sun, 21 Feb 2010 16:17:09 -0800

Ray Gosling case latest … news from CROI … Sexual Health Awareness Week